is approved for the treatment of acne vulgaris (and rosacea). Both nicotinamide and zinc oxide have anti-inflammatory properties. Severe comedonal acne is treated somewhat similarly to mild and ...

Acne is a chronic disease ofthe pilosebaceous follicle that affects mainly adolescents. It causes polymorph cutaneous lesions that may leave scars after regression. It is characterized by ...

480 patients with moderate to severe acne vulgaris were enrolled and randomized into one active treatment arm and one placebo control arm at the ratio of 1:1 to receive 50 mg ASC40 oral tablet ...

This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40 once-daily oral tablet for the ...